Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Clinical trial NCT06724237 · RECRUITING

Trial details

NCT number: NCT06724237
Sponsor: Eastern Cooperative Oncology Group
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Anaplastic Large Cell Lymphoma, ALK-Negative Follicular Helper T-Cell Lymphoma Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Peripheral T-Cell Lymphoma, Not Otherwise Specified

Start date: 2025-01-30
Primary completion: 2028-04-30
Enrollment: 294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.